Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
5.06M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
35K
-
Shares change
-
+35K
-
Total reported value, excl. options
-
$111K
-
Value change
-
+$111K
-
Number of buys
-
10
-
Price
-
$3.00
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q3 2024
10 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q3 2024.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35K shares
of 5.06M outstanding shares and own 0.69% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (34.5K shares), Nordwand Advisors, LLC (500 shares), NATIONAL BANK OF CANADA /FI/ (7 shares), Federation des caisses Desjardins du Quebec (1 shares), Rise Advisors, LLC (1 shares), Jaffetilchin Investment Partners, LLC (1 shares), Farther Finance Advisors, LLC (1 shares), MORGAN STANLEY (1 shares), TD Waterhouse Canada Inc. (1 shares), and OSAIC HOLDINGS, INC. (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.